Research on attitudes to animal medicines

Similar documents
Quality of veterinary medicines

Focus group on promotion of PhV for food producing animals MAH view. IFAH-Europe Tony Simon 23rd November 2016

Private Sector Perspectives IFAH (worldwide)

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

European trends in animal welfare policies and research and their potential implications for US Agriculture

Quality of veterinary medicines

Questions and Answers on the Community Animal Health Policy

Antimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

Special Eurobarometer 478. Summary. Antimicrobial Resistance

OIE activities on rabies: PVS, vaccine banks and the OIE twinning

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

RESTRAINING SYSTEMS FOR BOVINE ANIMALS SLAUGHTERED WITHOUT STUNNING WELFARE AND SOCIO-ECONOMIC IMPLICATIONS

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

EU Health Priorities. Jurate Svarcaite Secretary General PGEU

European poultry industry trends

Global animal production perspectives and correlated use of antimicrobial agents

MRSA found in British pig meat

OIE Conference on Veterinary Medicinal Products in the Middle East

Dr Bernard Vallat OIE Director General

Aerial view of the Faculty of Veterinary Medicine Utrecht

Proposal for a Regulation on veterinary medicinal products

Animal Law in Europe Progress and Challenges. Prof. Dr. Marita Giménez-Candela Master in Animal Law and Society Director

European Medicines Agency role and experience on antimicrobial resistance

Second Meeting of the Regional Steering Committee of the GF-TADs for Europe. OIE Headquarters, Paris, 18 December 2007.

international news RECOMMENDATIONS

Global action plan to combat antimicrobial resistance (AMR)

Speaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA)

CHALLENGES AND COLLABORATION

funded by Reducing antibiotics in pig farming

THE DEVELOPMENT OF A RISK BASED MEAT INSPECTION SYSTEM SANCO / 4403 / 2000

Actions for combatting Antimicrobial Resistance (AMR)

Consumers and Antibiotic Use: Perspectives and Marketing

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. on systems restraining bovine animals by inversion or any unnatural position

Building Competence and Confidence. The OIE PVS Pathway

How do people obtain antibiotics in European countries: an overview

The promise of aquaculture and the challenge of antimicrobial use

FVE and responsible use of antimicrobials

WHY STAKEHOLDER ENGAGEMENT IS CRITICAL TO OIE STRAY DOG INITIATIVE

Adolfo Sansolini Consultant, GAIA

LANAnC16 Handle and care for animals to enable them to work effectively

COMMISSION OF THE EUROPEAN COMMUNITIES

OIE international standards on Rabies:

EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment

Veterinary Legislation and Animal Welfare. Tania Dennison and David M. Sherman

Options for a global development and stewardship framework to combat AMR Consultation of Member States and relevant partners

OIE PVS Pathway including Veterinary Education

OIE International Solidarity: General Overview

The new EU Regulation on Animal Health (Animal Health Law)

Antimicrobial Resistance, yes we care! The European Joint Action

WHO global and regional activities on AMR and collaboration with partner organisations

NATIONAL CODE OF PRACTICE

OVERVIEW OF THE ONLINE PUPPY TRADE. Sarah Ross Companion Animals Lead Expert FOUR PAWS International

Antimicrobial Resistance

COPING WITH ANTIMICROBIAL RESISTANCE

Final Report. Part 1 Synthesis Report

Working Together for Animal Health Global Coordination of Animal Disease Research. Alex Morrow

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

The European AMR Challenge - strategic views from the human perspective -

European Goose Management Platform (EuroGMP)

a commitment to milk quality

Special Eurobarometer 445. Summary

ruma Cattle Responsible use of antimicrobials in Cattle production GUIDELINES

OIE Activities for the Containment of Antimicrobial Resistance. Dr Elisabeth Erlacher-Vindel, Deputy Head of the Scientific and Technical Department

Antimicrobial resistance (EARS-Net)

SFJZJ1 Maintain health and safety of dogs

EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017

Tail docking in pigs: beyond animal welfare

European Facts & Figures

OIE capacity-building activities

Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group

World Organisation for Animal Health (OIE) Sub-Regional Representation for Southern Africa

Global Coordination of Animal Disease Research. Alex Morrow

Global Communication on AMR in Animal Health: Tripartite and OIE Efforts

Council of the European Union Brussels, 13 June 2016 (OR. en)

Working for organic farming in Europe

Recommendations of the 3 rd OIE Global Conference on Animal Welfare

The PVS Tool. Part 4. Introduction to the concept of Fundamental Components and Critical Competencies

An agency of the European Union

Toward a Common Swine Industry Audit

Olivier FAUGERE DVM - Director National School for Veterinary Services - ENSV

EU Insights Perceptions on the human health impact of antimicrobial resistance (AMR) and antibiotics use in animals across the EU

MLCSL. Making the most of the 5th quarter Southampton University

SHAPING THE FUTURE OF THE VETERINARY PROFESSION

Better Training for Safer Food

REPORT FROM THE. 3 rd GLOBAL MILK QUALITY EXPERT FORUM

o VETERINARY IMMUNODIAGNOSTICS MARKET- GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECASTS TO 2022 Report ID: MRAM Publishing Date: July, 2017

Antibiotic Resistance

15 Becoming Cat Friendly Tips for improving your practice s approach to cat care from setting up the appointment to examination time

Unfair competition practices the impact on professional breeders and traders

What is the problem? Latest data on antibiotic resistance

Summary of the latest data on antibiotic consumption in the European Union

Managing AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan

The challenge of growing resistance

Epidemiology and Economics of Antibiotic Resistance

Promoting One Health : the international perspective OIE

Agricultural Competitiveness Green Paper

Transcription:

Research on attitudes to animal medicines Online survey among European citizens Roxane Feller IFAH-Europe Secretary General Brussels, 13 October 2016 1

Overview I. Aim II. Methodology III. Results 1. Right to medicines 2. Animal welfare 3. Disease prevention 4. Zoonoses 5. Cure 6. Food safety and sustainability 7. Legal compliance 8. Innovation 9. General awareness IV. Take-home messages and Commitment 2

I. Aim Get a good understanding of EU citizens perceptions and attitudes towards animal medicines and on the benefits they provide to society: treatment and prevention of diseases pets and farm animals food safety and public health 3

II. Methodology Methodology Online interviews Fieldwork period March / April 2016 Countries Denmark / Germany / the Netherlands / Poland / Spain / UK (6) Target group Sample Representative sample of European citizens: regional distribution, gender and age (> 18 years). Size = 6,000 respondents (1,000 per country) Balanced sample of the target group 4

III. Results 5

1. Animals have the same right to medicines as people 65% agree for pets 20% 16% 65% All animals are equal, but some are more equal than others Animal Farm, George Orwell 59% agree for farm animals 17% 25% 59% Yes No Don t know 6

2. Medicines have a positive impact on animal welfare 41% 19% 40% 60% don t know/think medicines have a positive impact on the welfare of farm animals Yes No Don t know 7

3. Prevention: animals should be vaccinated regularly 2/3 agree for pets 22% 12% 66% All animals are equal, but some are more equal than others Animal Farm, George Orwell 1/2 agree for farm animals 14% 32% 54% Yes No Don t know 8

4. Zoonoses: vaccination of animals helps prevent transfer of disease from animals to people 3/5 agree for pets 1/2 agree for farm animals 29% 13% 33% 12% 59% over 40% don t know /believe that vaccination of animals prevent disease transfer from animals to people 55% Yes No Don t know 9

5. Cure: animals are given medicines to treat them when sick Disease treatment 10% 3 out of 4 are aware for pets 15% 75% All animals are equal, but some are more equal than others Animal Farm, George Orwell 15% 2 in 3 are aware for farm animals 19% 66% Yes No Don t know 10

5. Cure: antibiotics are routinely given to farm animal even when they are not sick Antibiotic treatment 46% believe 43% 12% 46% 43% don t know Yes No Don t know 11

6. Food safety and sustainability Food quality +80% agree that healthy animals will produce better quality products (e.g. milk) Sustainable production 75 % agree that healthy animals enable a sustainable food production and supply Yes No Don t know 12

6. Food safety and sustainability Food safety 70 % don t know /agree that medicines given to farm animals make food safer 42% 29% 30% Yes No Don t know 13

7. Legal compliance Citizens 62% know: animal medicines are tested and reviewed before being sold. >1/2 are aware: use of antibiotics in farm animals is regulated and controlled by national authorities. Citizens >50% aren t aware: animal medicines meet same safety standards as medicines for people. >1/2 don t know: animal medicines are assessed by independent scientists before being licensed. 52% are unaware: prescription and sale of animal medicines is strictly regulated. 60% don t know: manufacturers of animal medicines comply with all legal requirements (production, distribution & sale). 14

7. Legal compliance 60% don t realise that manufacturers of animal medicines need to comply with all legal requirements (production, distribution and sale) before they can be used. 15

8. Innovation 53% agree that all new technologies should be allowed to help develop new medicines for animals 32% 14% 53% 68% agree that scientists should be allowed to use new technologies to develop new medicines 25% 7% 68% Yes No Don t know 16

9. General awareness: how well do you feel informed by the media in general regarding the use of animal medicines 17% fell well informed 17% don t know 17% 17% 66% 66% don t feel well informed Yes No Don t know 17

IV. Take-home messages and commitment 18 18

Take-home messages 1. Let s note that the animal health industry: investment in developing, testing and manufacturing safe, effective and quality medicines & vaccines R&D spend: 7.8 % of turnover 2. Don t forget that Europe has one of the world s most stringent system for licensing & controlling animal medicines &vaccines 3. Mind the gap: there is an urgent and serious need to increase public awareness about animal medicines & vaccines and to communicate on Benefits: animal health & welfare, human health and food safety Legal compliance: stringent regulation & control Responsible use: all key stakeholders are working together 19 19

Our commitment We as IFAH-Europe will continue to work together with authorities and stakeholders in animal health and welfare, human health and the food sectors to increase people s knowledge about animal medicines and vaccines, and to address public concerns. IFAH-Europe International Federation for Animal Health-Europe, AISBL 168 Avenue de Tervueren, 1150 Brussels, Belgium info@ifaheurope.org www.ifaheurope.org 20